Temocillin in ESBL-Enterobacteriaceae Infections
Condition(s):Infectious DiseaseLast Updated:February 6, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Infectious DiseaseLast Updated:February 6, 2023Completed
Condition(s):Urinary Tract InfectionsLast Updated:June 6, 2018Unknown status
Condition(s):Gram-Negative Bacterial Infections; Renal Failure Chronic Requiring HemodialysisLast Updated:January 5, 2016Completed
Condition(s):Pharmacokinetics; Antibacterial Agents; Infections, Bacterial; Infection; Drug Monitoring; TemocillinLast Updated:May 31, 2022Recruiting
Condition(s):BacteremiaLast Updated:May 3, 2023Recruiting
Condition(s):Infection; Liver Dysfunction; Urinary Tract InfectionLast Updated:May 31, 2022Recruiting
Condition(s):Urinary Tract InfectionsLast Updated:April 19, 2021Completed
Condition(s):Urinary Tract InfectionLast Updated:January 29, 2013Withdrawn
Condition(s):Urinary Tract InfectionsLast Updated:September 16, 2019Completed
Condition(s):Sepsis; Septic ShockLast Updated:April 18, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.